NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol. 2017;23(2):103-108. Published online 2017 May 10 DOI: https://doi.org/10.3350/cmh.2017.0103
|
Citations to this article as recorded by
Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Tharani Senavirathna, Armaghan Shafaei, Ricky Lareu, Lois Balmer
Antioxidants.2024; 13(4): 485. CrossRef Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study
Seul Ki Han, Myung Jae Seo, Taesic Lee, Moon Young Kim, Anna Di Sessa
PLOS ONE.2024; 19(5): e0303333. CrossRef Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD
I Sabinari, O Horakova, T Cajka, V Kleinova, MR Wieckowski, M Rossmeisl
Physiological Research.2024; (Suppl 1): S295. CrossRef Statins for the Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
Weiwei Dai, Baohong Xu, Peng Li, Junhua Weng
American Journal of Therapeutics.2023; 30(1): e17. CrossRef Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation
Sonia Samuel, Ahmad Abulawi, Raza Malik
Gastroenterology Insights.2023; 14(3): 249. CrossRef Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives
Marko Mitrovic, Gabriella Sistilli, Olga Horakova, Martin Rossmeisl
European Journal of Clinical Investigation.2022;[Epub] CrossRef Enfermedad hepática grasa relacionada a trastornos metabólicos
A. Fabrizzio Bardales Silva
Revista Médica Basadrina.2022; 15(4): 85. CrossRef Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case–control study
Huai Zhang, Kenneth I. Zheng, Pei-Wu Zhu, Sui-Dan Chen, Gang Li, Hong-Lei Ma, Liang-Jie Tang, Ou-Yang Huang, Christopher D. Byrne, Giovanni Targher, Xiao-Dong Wang, Ming-Hua Zheng
European Journal of Gastroenterology & Hepatology.2022; 34(8): 838. CrossRef Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
Raghu Ramanathan, Ahmad Hassan Ali, Jamal A. Ibdah
International Journal of Molecular Sciences.2022; 23(13): 7280. CrossRef Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
Hongmei Yan, Weiyun Wu, Xinxia Chang, Mingfeng Xia, Sicheng Ma, Liu Wang, Jian Gao
Biology of Sex Differences.2021;[Epub] CrossRef Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Vittoria Zambon Azevedo, Valesca Dall’Alba
Clinical Nutrition.2021; 40(6): 4275. CrossRef Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies
Maryam Ebadi, Stephen Ip, Rahima A. Bhanji, Aldo J. Montano-Loza
Nutrients.2021; 13(9): 3042. CrossRef Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification
Chien-Chih Chen, Wei-Chien Hsu, Han-Ming Wu, Jiun-Yi Wang, Pei-Yu Yang, I-Ching Lin
Medicina.2021; 57(8): 807. CrossRef Statins in Non-alcoholic Steatohepatitis
Jose D. Torres-Peña, Laura Martín-Piedra, Francisco Fuentes-Jiménez
Frontiers in Cardiovascular Medicine.2021;[Epub] CrossRef Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases
Robert J. Wong, Nandita Kachru, Diane J. Martinez, Meghan Moynihan, A. Burak Ozbay, Stuart C. Gordon
Journal of Clinical Gastroenterology.2021; 55(10): 891. CrossRef iTRAQ‑based quantitative proteomics analysis of the hepatoprotective effect of melatonin on ANIT‑induced cholestasis in rats
Dingnan Wang, Han Yu, Yunzhou Li, Zongying Xu, Shaohua Shi, Dou Dou, Lili Sun, Zhili Zheng, Xinghua Shi, Xiulan Deng, Xianggen Zhong
Experimental and Therapeutic Medicine.2021;[Epub] CrossRef Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine
Tingting Shi, Li Wu, Wenjun Ma, Liping Ju, Minghui Bai, Xiaowei Chen, Shourong Liu, Xingxin Yang, Junping Shi, Svein Haavik
Evidence-Based Complementary and Alternative Medicine.2020;[Epub] CrossRef Gut microbial fatty acid metabolites (KetoA and KetoC) affect the progression of nonalcoholic steatohepatitis and reverse cholesterol transport metabolism in mouse model
Neng Tanty Sofyana, Jiawen Zheng, Yuki Manabe, Yuta Yamamoto, Shigenobu Kishino, Jun Ogawa, Tatsuya Sugawara
Lipids.2020; 55(2): 151. CrossRef Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View
Rodrigo Valenzuela, Luis A. Videla
Nutrients.2020; 12(2): 499. CrossRef Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy
Salvatore Petta, Jie Ting, Stefania Saragoni, Luca Degli Esposti, Sanatan Shreay, Maria Letizia Petroni, Giulio Marchesini
Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(6): 1014. CrossRef Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database
Jérôme Boursier, Sanatan Shreay, Cecile Fabron, Elodie Torreton, Jeremy Fraysse
EClinicalMedicine.2020; 25: 100445. CrossRef Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model
Hwi-Jin Im, Seung-Ju Hwang, Jin-Seok Lee, Sung-Bae Lee, Ji-Yun Kang, Chang-Gue Son
Nutrients.2020; 12(8): 2433. CrossRef Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming
Soung Won Jeong
Diabetes & Metabolism Journal.2020; 44(5): 640. CrossRef Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
Clarissa Berardo, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Mariapia Vairetti, Andrea Ferrigno
International Journal of Molecular Sciences.2020; 21(24): 9646. CrossRef A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
Amedeo Lonardo, Simonetta Lugari, Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Mauro Maurantonio
Acta Diabetologica.2019; 56(4): 385. CrossRef Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures
Stefania Lama, Daniela Vanacore, Nadia Diano, Carla Nicolucci, Sonia Errico, Marcello Dallio, Alessandro Federico, Carmelina Loguercio, Paola Stiuso
Scientific Reports.2019;[Epub] CrossRef Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approach
Sandra A. Soto‐Alarcón, Macarena Ortiz, Paula Orellana, Francisca Echeverría, Andrés Bustamante, Alejandra Espinosa, Paola Illesca, Daniel Gonzalez‐Mañán, Rodrigo Valenzuela, Luis A. Videla
BioFactors.2019; 45(6): 930. CrossRef The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Yan-Xiao Ji, Zan Huang, Xia Yang, Xiaozhan Wang, Ling-Ping Zhao, Pi-Xiao Wang, Xiao-Jing Zhang, Michele Alves-Bezerra, Lin Cai, Peng Zhang, Yue-Xin Lu, Lan Bai, Mao-Mao Gao, Huan Zhao, Song Tian, Yong Wang, Zhi-Xiang Huang, Xue-Yong Zhu, Yan Zhang, Jun Go
Nature Medicine.2018; 24(2): 213. CrossRef Prevention and management of gastroesophageal varices
Yeon Seok Seo
Clinical and Molecular Hepatology.2018; 24(1): 20. CrossRef Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action
Eleonora Scorletti, Christopher D. Byrne
Molecular Aspects of Medicine.2018; 64: 135. CrossRef NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson
Current HIV/AIDS Reports.2018; 15(3): 212. CrossRef Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction
Lucienne Juillerat-Jeanneret, John-David Aubert, Josip Mikulic, Dela Golshayan
Journal of Medicinal Chemistry.2018; 61(22): 9811. CrossRef Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases
Francesca Bonomini, Elisa Borsani, Gaia Favero, Luigi F. Rodella, Rita Rezzani
Nutrients.2018; 10(9): 1135. CrossRef
|